BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26797273)

  • 1. MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma.
    Wang X; Jiang F; Song H; Li X; Xian J; Gu X
    Biochem Biophys Res Commun; 2016 Feb; 470(3):620-626. PubMed ID: 26797273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
    Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
    J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA-200a induce cell apoptosis in renal cell carcinoma by directly targeting SIRT1.
    Fu H; Song W; Chen X; Guo T; Duan B; Wang X; Tang Y; Huang L; Zhang C
    Mol Cell Biochem; 2018 Jan; 437(1-2):143-152. PubMed ID: 28717923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-302c-3p inhibits renal cell carcinoma cell proliferation by targeting Grb2-associated binding 2 (Gab2).
    Gu DH; Mao JH; Pan XD; Zhu H; Chen X; Zheng B; Shan Y
    Oncotarget; 2017 Apr; 8(16):26334-26343. PubMed ID: 28412750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.
    Zhai Q; Zhou L; Zhao C; Wan J; Yu Z; Guo X; Qin J; Chen J; Lu R
    Biochem Biophys Res Commun; 2012 Mar; 419(4):621-6. PubMed ID: 22369946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8.
    Liu F; Chen N; Xiao R; Wang W; Pan Z
    Biochem Biophys Res Commun; 2016 Nov; 480(1):87-93. PubMed ID: 27717821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
    Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
    J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells.
    Pengcheng S; Ziqi W; Luyao Y; Xiangwei Z; Liang L; Yuwei L; Lechen L; Wanhai X
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
    Li G; Chong T; Xiang X; Yang J; Li H
    Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
    Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
    Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of microRNA-1274a induces cell apoptosis through regulation of BMPR1B in clear cell renal cell carcinoma.
    Yoshino H; Yonezawa T; Yonemori M; Miyamoto K; Sakaguchi T; Sugita S; Osako Y; Tatarano S; Nakagawa M; Enokida H
    Oncol Rep; 2018 Jan; 39(1):173-181. PubMed ID: 29192325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.
    Yoshino H; Yonemori M; Miyamoto K; Tatarano S; Kofuji S; Nohata N; Nakagawa M; Enokida H
    Oncotarget; 2017 Mar; 8(13):20881-20894. PubMed ID: 28152509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway.
    Lou G; Dong X; Xia C; Ye B; Yan Q; Wu S; Yu Y; Liu F; Zheng M; Chen Z; Liu Y
    J Exp Clin Cancer Res; 2016 Jan; 35():14. PubMed ID: 26790956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer.
    Zaman MS; Thamminana S; Shahryari V; Chiyomaru T; Deng G; Saini S; Majid S; Fukuhara S; Chang I; Arora S; Hirata H; Ueno K; Singh K; Tanaka Y; Dahiya R
    PLoS One; 2012; 7(11):e50203. PubMed ID: 23189187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
    Lin C; Li Z; Chen P; Quan J; Pan X; Zhao L; Zhou L; Lai Y; He T; Xu W; Xu J; Guan X; Li H; Yang S; Hu Y; Lai Y
    Life Sci; 2018 Sep; 209():481-489. PubMed ID: 30138594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
    Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
    Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.
    Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
    Biomed Pharmacother; 2019 Feb; 110():656-666. PubMed ID: 30551118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2.
    Lu R; Ji Z; Li X; Qin J; Cui G; Chen J; Zhai Q; Zhao C; Zhang W; Yu Z
    Tumour Biol; 2015 Sep; 36(9):6691-700. PubMed ID: 25813153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1-Nrf2, Tgfβ1/2, and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice.
    Wei J; Zhang Y; Luo Y; Wang Z; Bi S; Song D; Dai Y; Wang T; Qiu L; Wen L; Yuan L; Yang JY
    Free Radic Biol Med; 2014 Feb; 67():91-102. PubMed ID: 24161443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.
    Lu R; Ji Z; Li X; Zhai Q; Zhao C; Jiang Z; Zhang S; Nie L; Yu Z
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):387-97. PubMed ID: 24384875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.